Kshivets O. Cancer, Synergetics, Computer Sciences and Alive Supersystems

Click here to load reader

download Kshivets O. Cancer, Synergetics, Computer Sciences and Alive Supersystems

of 31

Embed Size (px)

Transcript of Kshivets O. Cancer, Synergetics, Computer Sciences and Alive Supersystems

  • Early Detection and Phase Transitions in System Malignancy-Human OrganismOleg Kshivets, M.D., Ph.D.Siauliai Cancer Center, LithuaniaAACR Special Conference: The Biology and Genetics of Early Detection & Chemoprevention of CancerMiami, Florida, The USA, 1999

    *

  • Abstract: EARLY DETECTION AND PHASE TRANSITIONS IN SYSTEM MALIGNANCY-HUMAN ORGANISM Oleg Kshivets Siauliai Cancer Center, Siauliai, Lithuania Purpose: This research studied homeostasis parameters, typical for two extreme states of phase transition: early malignancy (strategic purpose of early detection) and invasive cancer (C). Methods: Basis of this research was the data of 1524 cancer patients (CP) with pathologic stage (T1-4N0-2M0-1G1-4): 655 gastric CP (GCP), 525 lung CP (LCP) and 344 bladder CP (BCP) operated and monitored in clinic 1970-1998. All CP had preoperation examination including peripheral blood count, biochemical tests of venous blood using usual unified methods, clinical, anthropometric, X-ray examination, endoscopy, sonography, electrocardiography and also doctors examination, if required, computed tomography and radioisotope scanning. After operations the data of intraoperational investigation, information on character of surgery, complications, morphologic C characteristics (size, TNMG, growth, histology, etc.) was registrated. Representativeness of samplings was reached by means of randomization based on unrepeated random selection. Multiple correspondence analysis (A), clustering, A of variance, confirmatory factor A, structural equation modeling and Monte Carlo simulation were used to determine any significant overall regularities between malignancy and CP organism. Results: Using complex system analysis, simulation modeling in terms of synergetics, evoinformatics, statements from theories of Hopf, Landau, Turing and Marchuk it was discovered that system C-patients homeostasis consecutively passed through three phase transitions: 1) phase transition norm--oncobackground; 2) phase transition oncobackground--early malignancy; 3) phase transition early malignancy--invasive C. If diagnosis of first two phase transitions depended on outcomes of early detection and diagnosis, identification of third phase transition resulted in effectiveness of treatment process and 5-year survival of CP. It was also verified that most important figure of this transition for human was quantity of C cell population in organism and average critical threshold of this population was 4.189e+9 per human organism. Below such value there was a temporal dynamic equilibrium between C and patients homeostasis and 5-year survival of radically operated CP tended to be 100%. Excess over this threshold resulted in irreversible consequences when effectiveness of treatment went down up to 10-15%. It was discovered that phase transition of early malignancy into invasive C of any localization significantly depended on: 1) input level of blood cell circuit; 2) ratio of C cell population quantity to blood cell subpopulations in integral CP organism (cell ratio factors); 3) C characteristics (C cell population quantity in CP organism, TNMG); 4) some blood biochemical factors; 5) anthropometric data.

    *

  • Samplings:Lung Cancer Patients (T1-4N0-2M0-1).525Gastric Cancer Patients (T1-4N0-2M0-1).655Bladder Cancer Patients (T1-4N0-2M0-1)344In All ......1524

    Patients with Non-Malignant Pathology.3977 Practically Healthy Old People...1464

    *

  • Prognostic Role of Cancer Diameter

    EMBED STATISTICAGraph

    *

  • Main Problem of Analysis of Living Supersystems: Phenomenon of Combinatorial ExplosionAverage Number of Routine Blood Parameters: 28Number of Possible Combination for Random Search:.... n!=28!=3.049e+29 Computer Operation Time of The 7G Teracomputer (1000TFLOPS) (The 21st Century) 9.7 Million Years

    *

  • BasisNP RP P n! n*n*2(e+n) or n log n n AI CSA+S+B SM

    *

  • Model Cancer Cells(Cr)--Human Killer Cells(Kl)r=Cr(1-KlCr/Kl);l=(KlCr/Kl)[25Cr/(4.189++2.5Cr)-Cr-1];

    *

  • Regularities between Dynamics Cancer Cell Population and Patient's Survival Rate

    *

  • Phase Transitions in System Homeostasis-Malignancy

    *

  • The Three Phase Transitions in the System Malignancy-Humans Organism

    *

  • Phase Transition Early Malignancy into Invasive Cancer

    *

  • Role of Cell Ratio Factors in Phaze Transition Erly Cancer into Invasive Cancer

    *

  • Regression Models (Lym/CC--Life Span of GCP, n=224; BCP, n=120 and LCP, n=162; 18th Degree Polynomial Fit): y=a+bx+cx2+dx 3+...

    *

  • Cell Ratio Factors in Prognosis5-Year Survival Cancer Patients

    *

  • Results of Monte Carlo Simulation

    *

  • Results of Structural Equotion Modeling

    *

  • Early and Differential Diagnosis of Malignancies

    *

  • The Results of Multiple Correspondence and Claster Analysis of Blood Indexes in Oncoscreening

    *

  • Interdependencies between Blood Parameters, Indexes and Cancer Cell Population

    *

  • Interdependencies between Blood Indexes and Immune System of Cancer Patients

    *

  • Networks Between Phase Transition Early Cancer-Invasive Cancer, Life Span and Homeostasis Data

    *

  • Superoncoscreeng-1.0

    *

  • Superoncodiagnos-1.0

    *

  • Superoncodiagnosis of Metastasazing-1.0

    *

  • Superoncoimmunology-1.0

    *

  • Superoncoprognosis-1.0

    *

  • Total Monitoring System

    *

  • Conclusions:1. System Cancer-patients homeostasis consecutively passed through three phase transitions: norm-oncobackground; oncobackground-early malignancy; early malignancy-invasive cancer. 2. Most important figure of this transition for human was quantity of cancer cell population in organism and average critical threshold of this population was 4.189e+9 per human organism. 3. Phase transition of early malignancy into invasive cancer of any localization significantly depended on: input level of blood cell circuit; ratio of cancer cell population quantity to blood cell subpopulations in integral cancer patients organism (cell ratio factors); malygnancy characteristics (cancer cell population quantity in organism, TNMG); some blood biochemical factors and anthropometric data.

    *

  • Patents:1. Kshivets O.M. Method of Screening and Differential Diagnosis of Malignant Neoplasms// Patent from 27.04.92.-N2045072.-28pp.. 2. Kshivets O.M. Method of Prognosis of Survival Rate of Radically Operated Oncopatients// Patent from 10.02.94.-N2101704.-24pp. .3. Kshivets O.M. Method of Prognosis of Survival Rate of Non-Radically Operated Oncopatients// Patent from 14.03.94.-N2104536.-10pp. .4. Kshivets O.M. Method of Early and Differential Immunodiagnosis of Malignancies// Patent from 24.10.95.-N2107290.-12pp. .5. Kshivets O.M. Method of Immunodiagnosis of Distant Metastases of Oncopatients// Patent from 06.10.95.-N2107295.-8pp. .6. Kshivets O.M. Method of Immunodiagnosis of Generalization of Oncopatients// Patent from 09.10.95.-N2107294.-12pp. .7. Kshivets O.M. Method of Immunodiagnosis of Early and Invasive Oncopathology for Patients// Patent from 04.05.95.-N2107293.-14pp. .8. Kshivets O.M. Method of Differential Diagnosis of Oncopathology and Pre-Cancer or Non-Malignant Pathology// Patent from 08.11.94.-N2114431.-18pp.

    *

  • Patents:. 9.Kshivets O.M. Method of Measuring the Size of Malignant Neoplasms and Total Quantity of Malignant Cells in Oncopatients Organism Based on the Homeostasis Parameters// Application for Patent from 04.05.95.-N95107201/012623.-8pp. (Positive Decision)..10. Kshivets O.M. Method of Diagnosis of Distant Metastases of Oncopatients// Application for Patent from 03.11.95.-N95118236/032006.-12pp. (Positive Decision)..11. Kshivets O.M. Method of Diagnosis of Generalization of Oncopatients// Application for Patent from 20.10.95.-N95117904/031312.-12pp. (Positive Decision)..12. Kshivets O.M. Method of Diagnosis of Early and Invasive Oncopathology for a Single Patient// Application for Patent from 06.10.95.-N95117338/029690.-13pp. (Positive Decision)..13. Kshivets O.M. Method of Diagnosis of Malignant Neoplasms Metastasizing in Regional Lymphatic Nodules of a Concrete Patient// Application for Patent from 29.09.95.-N95116510/028981.-10pp. (Positive Decision)..14. Kshivets O.M. Method of Measuring the Size of the Malignancy and Total Quantity of Malignant Cells in the Oncopatients Organism Based on the Immunogram// Application for Patent from 04.05.95.-N95107200/012622.-9pp. (Positive Decision)..15. Kshivets O.M. Method of Immunodiagnosis of Regional Metastases of Oncopatients// Application for Patent from 06.10.95.-N95117049/029707.-9pp. (Positive Decision).

    *

  • Address: Oleg Kshivets, M.D., Ph.D. Thoracic Surgeon Department of Surgery Siauliai Cancer CenterTilzes:42-16, Siauliai, LT78206, LithuaniaTel. (37041)416614okshivets@yahoo.com kshivets@gmail.comhttp//:myprofile.cos.com/Kshivets

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *

    *